These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2411987)

  • 1. [Prophylaxis of recurrence of superficial bladder tumor by diluted postoperative continuous intravesical instillation of anti-tumor solutions].
    Uchida T; Kobayashi K; Honda N; Arakawa T; Omata T; Endo T; Ishibashi A; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1985 Mar; 76(3):354-9. PubMed ID: 2411987
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylactic treatment for superficial bladder cancer following transurethral resection.
    Hirao Y; Okajima E; Ohara S; Ozono S; Hiramatsu T; Yoshida K; Yamada K; Aoyama H; Hashimoto M; Watanabe S
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S85-90. PubMed ID: 3117402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].
    Lingnau A; Miller K; Steiner U; Jentzmik F; Weikert S; Schostak M
    Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma levels during intravesical instillation of mitomycin-C.
    Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
    Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prophylactic intravesical instillation therapy with adriamycin (ADM) and mitomycin C (MMC) in patients with superficial bladder cancer].
    Ozaki Y; Tsushima T; Nasu Y; Akagi T; Obama T; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1493-500. PubMed ID: 3100850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical studies on intravesical instillation therapy for bladder cancer].
    Yamanaka H; Kaburagi Y; Imai K; Miki M
    Hinyokika Kiyo; 1983 Nov; 29(11):1427-32. PubMed ID: 6428193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.
    Huland H; Otto U; Droese M; Klöppel G
    J Urol; 1984 Jul; 132(1):27-9. PubMed ID: 6427483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA; Van Helsdingen PJ; Kramer AE
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH; Bai JL; Zhang SS; Ma PC; Wan JH
    Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C.
    Isaka S; Okano T; Shimazaki J; Igarashi T; Murakami S; Higa T; Ishikawa T; Zama S; Kataumi S; Kataumi Z
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S77-80. PubMed ID: 3117401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood and tissue levels of mitomycin C after intravesical instillation].
    Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
    Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
    Soloway MS
    J Urol; 1980 Apr; 123(4):461-6. PubMed ID: 6767860
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of mitomycin C perfusion after bladder tumor surgery].
    Zhou CL
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.